Paul Hastings
2012 - OncoMed Pharmaceuticals
In 2012, Paul Hastings earned a total compensation of $569.7K as Chairman, President & Chief Executive Officer at OncoMed Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $131,480 |
|---|---|
| Salary | $438,265 |
| Total | $569,745 |
Hastings received $438.3K in salary, accounting for 77% of the total pay in 2012.
Hastings also received $131.5K in non-equity incentive plan.
Rankings
In 2012, Paul Hastings' compensation ranked 8,329th out of 11,487 executives tracked by ExecPay. In other words, Hastings earned more than 27.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,329 out of 11,487 | 28th |
Division Manufacturing | 3,019 out of 4,253 | 29th |
Major group Chemicals And Allied Products | 803 out of 1,198 | 33rd |
Industry group Drugs | 578 out of 920 | 37th |
Industry Pharmaceutical Preparations | 451 out of 700 | 36th |
Source: SEC filing on April 28, 2014.
Hastings' colleagues
We found two more compensation records of executives who worked with Paul Hastings at OncoMed Pharmaceuticals in 2012.